Menu

降压药依普利酮的价格多少钱

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

It is an oral drug with definite efficacy in the treatment of hypertension, heart failure and myocardial infarction. It was first approved for marketing in the United States in 2002. It has not yet been officially launched in China. In recent years, more and more evidence has shown that other tissues, especially the brain, heart and blood vessels, can independently synthesize aldosterone. Not only that, it can also directly affect blood pressure, damage the heart, brain, kidneys and other organs, seriously affecting the health of patients.

Eplerenone is a selective aldosterone receptor antagonist that only acts on mineralocorticoid receptors and does not act on androgen and progesterone receptors. It has fewer side effects. In treating patients with stage 1 and 2 hypertension, eplerenone has similar efficacy rates and reductions in systolic and diastolic blood pressure as enalapril.

In the study, it was also found that the antihypertensive effect of eplerenone in patients with low-renin hypertension was significantly better than that of losartan. For patients with hypertension who are poorly controlled by ARB alone, adding eplerenone (50~100 mg·d) for 8 weeks can further enhance the effect of reducing DBP (diastolic blood pressure) and SBP (systolic blood pressure).

The effect of eplerenone as an antihypertensive drug is very significant, and patients cannot help but want to know its price. At present, the price of the Indian version of eplerenone is relatively low. The specification is 50mg*100 tablets and the price is around $420. It is only sold in local pharmacies in India. Patients can go abroad to buy it by themselves, or contact the medical companion travel service to learn about the formal purchase method.

The Indian version is taken orally. The initial dose for treating adult patients with hypertension is 50 mg, once a day; the maintenance dose is 50 mg, 1-2 times a day. The maximum dose is 100 mg/day and patients should not overdose.

Recommended related hot articles: /newsDetail/79956.html

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。